Docetaxel Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy in Triple Negative Breast Cancer (INTEGRAL)

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date3/12/21 → …